Glucose Metabolism / Insulin Resistance

Glucose Metabolism /
Insulin Resistance

Role of Traditional Risk Factors vs HAART in the Development of Metabolic Syndrome - 2/09/07

Incidence of Metabolic Syndrome in HIV Positive Adults 1/09/07

Rosiglitazone and Metformin Improve Insulin Sensitivity, but Minimal Effect on Body Fat 12/12/06

Single Dose of Amprenavir Does Not Induce Insulin Resistance - 12/09/05

Visceral Fat Mass and the Risk of Insulin Resistance and Cardiovascular Disease - 12/09/05

Treatment with Pioglitazone But Not with Fenofibrate Improves HAART-related Metabolic Syndrome - 2/14/05

Body Composition and Metabolic Changes in Treatment-naive HIV Patients Randomized to Didanosine and Stavudine vs. Abacavir and Lamivudine - 02/09/05

Impaired Glucose Tolerance

• PI-Associated History

• Reported Incidence

• Insulin Resistance

• Mechanisms of Insulin Resistance

• Evaluation and Diagnosis

• Diagnostic Criteria for Diabetes

• Diagnostic Criteria for Impaired Glucose Tolerance

• Impact of Body Composition Changes

• Fasting and Two-Hour Glucose Levels

• Fasting and Two-Hour Insulin Levels

• Metabolic Profile in the HIV Lipodystrophy Syndrome

• Management Strategies

• Drug Therapies

• Metformin – Impact on PAI-1 and tPA Antigen Levels

• Metformin – Correlation Between Change in Insulin and tPA Levels

• Metformin – Impact on PAI-1 and tPA Antigen Levels Results

• Summary and Conclusions